TrialNeuro-oncology2010

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.

Jeffrey J Raizer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.